BOC Sciences provides custom ether lipid synthesis services for research teams working in drug delivery, lipidomics, membrane biophysics, and bioactive lipid discovery. Built on our broader custom lipid synthesis capabilities, our program covers alkyl ether, alkenyl ether (plasmalogen), dialkyl ether, and cyclic ether lipid classes — from chiral backbone construction and stereoselective ether bond formation to headgroup installation, isotope and functional labeling, purification, and orthogonal structural confirmation, with analytical documentation delivered for every batch.
Ether lipid synthesis is the chemical preparation of glycerol-based lipids in which one or more fatty chains are attached through a carbon–oxygen ether bond instead of the more common ester linkage. In mammalian-type ether lipids, the ether bond connects an alkyl or (Z)-alkenyl chain to the sn-1 position of glycerol: the alkyl-linked class is described as plasmanyl, while the alkenyl-linked class — the plasmalogens — carries an acid-sensitive vinyl ether bond. Because ether-linked backbones resist phospholipase cleavage and change how membranes pack, fuse, and signal, ether lipids act as signaling molecules, membrane stabilizers, and disease-relevant biomarkers in cardiovascular, neurological, and metabolic research.
Natural ether lipids occur at low abundance in biological extracts, and the vinyl ether bond that defines plasmalogens degrades under acidic and oxidative conditions, which makes isolation from tissues impractical for most research programs. Access therefore depends on total synthesis: multi-step routes that control sn-position stereochemistry, install long alkyl or stereodefined alkenyl chains at defined positions, preserve (Z)-vinyl ether geometry, and attach polar headgroups with high fidelity.
We synthesize plasmanyl-type and related alkyl ether lipids containing a stable C-O-C linkage, most commonly at the sn-1 position of glycerol.
BOC Sciences develops routes to plasmenyl lipids and plasmalogen analogs containing the characteristic O-(Z)-vinyl ether linkage at the sn-1 position.
We prepare ether lipids in which both glycerol hydroxyl positions carry ether-linked hydrophobic chains, providing architectures distinct from conventional ester-containing phospholipids.
Our chemists also support lipid-like targets containing cyclic ether motifs where ring stereochemistry and lipid-chain installation must be controlled within a multistep synthesis.
Our stable isotope labeling capabilities support ether lipids containing defined isotopic labels for quantitative and tracing applications.
We prepare fluorescent lipids based on ether lipid scaffolds for imaging, localization, uptake, and membrane-distribution studies.
Click-compatible ether lipids can be prepared with compact reactive handles that enable downstream bioorthogonal coupling while retaining the required lipid architecture.
BOC Sciences prepares biotinylated lipids based on alkyl, alkenyl, or dialkyl ether lipid scaffolds.
BOC Sciences supports research teams with fully custom ether lipid synthesis — from route design and chiral backbone preparation to vinyl ether construction, headgroup installation, purification, and orthogonal structural confirmation, delivered with complete analytical documentation.
Ether lipid synthesis often requires several orthogonal chemistries within one route. BOC Sciences integrates stereochemistry control, ether-bond construction, selective acylation, headgroup chemistry, purification, and structural analysis to develop practical routes for complex targets.
Whether you have a complete target structure or only a desired chain composition, headgroup, labeling position, and research application, our chemists can evaluate the molecule and propose a practical route. Projects can cover full synthesis or selected stages such as intermediate preparation, vinyl ether construction, headgroup installation, modification, purification, or structural confirmation.
BOC Sciences reviews the target structure with the client — chain composition, sn-stereochemistry, headgroup, labeling requirements, quantity, and intended application — then confirms a practical route, flags stability-sensitive steps, and agrees on specifications and deliverables before work begins.
Our chemists prepare chiral glycerol synthons and activated alkyl or stereodefined alkenyl chain donors, then form the ether bond under moisture-controlled conditions, monitoring donor conversion and checking regioselectivity at this stage so that problems do not propagate downstream.
The lipid is completed through sn-2 acylation and headgroup installation, then purified on deactivated silica and by preparative chromatography. Identity, purity, vinyl ether geometry, and stereochemistry are confirmed by orthogonal analytical methods before the batch is cleared for release.
Clients receive the ether lipid packaged under inert atmosphere with low-temperature protection, together with the full analytical report, storage and handling guidance, and complete project records documenting every intermediate and reaction condition for reproducibility.
Plasmalogens hydrolyze under trace acid and isomerize toward the E-isomer under the same conditions, so a route that works on paper can still deliver a partially degraded, geometry-scrambled product. BOC Sciences sequences every project so that no acidic reagent, acidic resin, or unbuffered silica contacts the molecule after vinyl ether installation. Workups use neutralized solvents with antioxidant protection, chromatography runs on amine-deactivated stationary phases, and final products are dried, packed under argon, and shipped cold. 1H NMR vinyl ether signals and coupling constants are checked at multiple checkpoints, so (Z)-content is tracked rather than assumed across the whole route.
Long-chain alkylating agents react sluggishly with hindered glycerol alkoxides and compete with elimination to terminal alkenes, while poorly protected diols give mixtures of sn-1 and sn-2 ethers that are difficult to separate. We address conversion by activating donors as iodides or triflates when needed, screening base, solvent, and phase-transfer systems, and monitoring donor consumption in-process. Regioselectivity is handled by strategy rather than correction: orthogonal protection fixes the reactive hydroxyl before alkylation, and qualified building blocks ensure the chain is installed once, at the right position, without reworking mixed fractions.
Zwitterionic phosphocholine ether lipids streak on ordinary silica, tail into salt fractions, and resist crystallization, so conventional purification can consume most of a batch. Our workflows use base-deactivated stationary phases and ammonia-containing eluent systems, then polish with HPLC testing using charged-aerosol or evaporative-light-scattering detection that sees lipids without chromophores. Desalting, residual detergent removal, and solvent exchange into formulation-compatible solvents are handled as part of purification rather than left to the client. Where side fractions matter — de-etherified byproducts or acyl-migration species — they can be isolated and retained as references through our impurities synthesis support.
Plasmanyl and plasmenyl analogues of the same chain pair differ by exactly 2.0157 Da, run close in reversed-phase chromatography, and can be misassigned when only nominal-mass MS is available — a recurring source of incorrect structures in lipid panels. We resolve each assignment orthogonally: LC-MS/MS fragment patterns distinguish the two linkage types, LC-HRMS confirms the exact mass difference, and 1H NMR verifies the vinyl ether proton directly. Where needed, selective derivatization that shifts only the vinyl ether species provides a second line of evidence, and the complete assignment package is delivered with the batch.
BOC Sciences combines a broad range of lipid-related starting materials and intermediates with established synthesis technologies and experienced lipid chemistry scientists to help evaluate your problem, optimize the synthetic route, and develop a practical solution for your target structure.
BOC Sciences supports alkyl ether, alkenyl ether, dialkyl ether, cyclic ether, phospholipid, and functionalized lipid structures. This broad synthetic scope is valuable when a project moves beyond a standard phospholipid and requires unusual chain architecture, differentiated glycerol positions, stereochemistry control, or a non-native analytical or imaging handle.
The order of ether construction, protecting-group removal, acylation, headgroup installation, and final modification can determine whether a difficult lipid synthesis succeeds. Our chemists design routes around the chemical liabilities of the target, including vinyl ether instability, polyunsaturated chains, long hydrophobic intermediates, charged headgroups, and functional labels that may not tolerate every reaction condition.
Complex ether lipids often require analytical feedback during synthesis rather than only a final identity check. We connect reaction monitoring, chromatographic purification, mass analysis, and NMR interpretation with route development so that low conversion, side products, positional isomers, or incorrect ether-bond assignments can be identified and addressed during the project.
Clients can specify chain length, degree of unsaturation, sn-2 acyl composition, phospholipid headgroup, spacer, isotope position, fluorescent label, click handle, affinity tag, or other structural elements. This modular approach supports both close analog series and highly customized ether lipid probes without restricting the project to a small catalog of predefined structures.
Client Needs: A lipidomics core facility required a deuterated plasmanylcholine internal standard — 1-O-[d31]hexadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine — for absolute quantification of ether-linked PC species in large plasma panels. No catalog supplier offered this structure with the isotope label positioned in the sn-1 alkyl chain.
Challenges: The d31 label had to survive Williamson coupling without H/D scrambling, the polyunsaturated sn-2 chain had to be installed without oxidation, and the final zwitterionic lipid had to be purified free of salt and lyso-species that would distort quantification.
Solution: We prepared d31-hexadecanol from d31-palmitic acid, converted it into a mesylate donor, and coupled it to enantiopure (R)-solketal under low-temperature conditions that prevent H/D exchange. After deprotection, sn-2 acylation, and phosphocholine installation, the product was purified on deactivated silica and polished by preparative HPLC. Identity, isotope pattern, and sn-configuration were confirmed by 1H and 13C NMR, LC-HRMS, and chiral analysis.
Outcome: The facility received a multimilligram batch with a clean isotope envelope and a complete data package, enabling consistent quantification across more than thirty ether-PC species in their biomarker research panels.
Client Needs: A neurochemistry group studying the antioxidant behavior of plasmalogens needed a plasmenylethanolamine analog bearing a defined docosahexaenoyl (22:6) chain at sn-2 for radical-trapping kinetics experiments. Material previously obtained elsewhere arrived partially hydrolyzed with mixed vinyl ether geometry.
Challenges: The vinyl ether had to survive sn-2 acylation and headgroup installation, the highly oxidation-prone docosahexaenoyl chain had to be protected throughout purification, and the (Z)-geometry of the alkenyl chain had to be retained without acidic purification steps.
Solution: Our route installed the (Z)-1-alkenyl chain from a stereodefined alkenyl donor under neutral conditions, followed by low-temperature sn-2 acylation with docosahexaenoyl chloride and phosphoramidite-based ethanolamine headgroup installation. Every purification used neutralized silica, antioxidant-stabilized solvents, and inert-atmosphere handling, and the material was packed in amber vials for cold shipment. Vinyl ether geometry was confirmed by diagnostic 1H NMR signals and tracked at three in-process checkpoints.
Outcome: The client received material with retained (Z)-geometry and no detectable lyso-species, enabling clean kinetic measurements of radical-driven vinyl ether consumption in their oxidation model.
Client Needs: A cell biology team wanted an ω-alkynyl ether lipid — 1-O-(hexadec-15-ynyl)-2-oleoyl-sn-glycero-3-phosphocholine — to trace ether lipid insertion into cell membranes by post-labeling with an azido-fluorophore, matching the membrane behavior of natural C16 alkyl ether lipids.
Challenges: The terminal alkyne had to survive the full synthesis without partial reduction or side reactions, the final lipid had to be free of copper residues that interfere with downstream click labeling, and the analog had to remain membrane-active rather than phase-separating.
Solution: We synthesized the 15-hexadecynyl mesylate donor without metal-catalyzed steps, coupled it to (S)-solketal, and completed sn-2 acylation and phosphocholine installation under conditions that left the terminal alkyne untouched. Normal-phase and reversed-phase purifications were validated to exclude metal contamination, and click reactivity was verified in-house against a fluorescent azide before release, together with full spectral documentation.
Outcome: The probe labeled ether-lipid-rich membranes with low background, supporting the team's pulse-chase imaging experiments without detectable disruption of membrane morphology.
Ether lipids are characterized by a hydrophobic chain connected to the glycerol backbone through an ether linkage rather than the ester linkage commonly found in conventional glycerolipids. In many mammalian ether phospholipids, the ether-linked chain occupies the sn-1 position, while the sn-2 position carries an acyl chain and the sn-3 position contains a polar headgroup such as phosphocholine or phosphoethanolamine. This linkage influences chemical stability, membrane organization, and metabolic behavior. Synthetic design therefore requires control over ether bond type, chain composition, glycerol stereochemistry, positional substitution, and headgroup structure.
Plasmanyl and plasmenyl lipids are both ether lipids, but they differ in the linkage at the sn-1 position. Plasmanyl lipids contain a conventional alkyl ether, whereas plasmenyl lipids, commonly called plasmalogens, contain an alkenyl or vinyl ether linkage adjacent to the oxygen atom. The vinyl ether changes the chemical reactivity, oxidation behavior, and analytical properties of the molecule. Because plasmanyl and plasmenyl species can have closely related masses and chromatographic behavior, reliable structural assignment often requires complementary evidence from LC-MS/MS, high-resolution mass spectrometry, NMR, or other linkage-sensitive analytical approaches rather than relying on a single measurement.
Plasmalogen synthesis is challenging primarily because the characteristic vinyl ether linkage must be constructed with the required geometry and then preserved through subsequent transformations. The vinyl ether can be sensitive to acidic conditions, while the overall molecule may also require stereochemical control of the glycerol backbone, selective sn-2 acylation, and installation of a polar phospholipid headgroup. Targets containing polyunsaturated chains introduce additional oxidation concerns. Successful synthesis therefore depends on careful reaction sequencing, protecting-group selection, stereoselective vinyl ether construction, mild downstream chemistry, and purification methods selected specifically for the stability and amphiphilic properties of the target plasmalogen.
Yes. BOC Sciences provides custom synthesis of alkyl ether lipids, alkenyl ether lipids and plasmalogens, dialkyl ether lipids, cyclic ether-containing lipids, and structurally modified analogs. Clients may define the sn-1 ether chain, sn-2 acyl chain, glycerol stereochemistry, polar headgroup, spacer, or other structural features according to their research objectives. For targets without an established synthetic route, our chemists can evaluate building-block availability, ether bond formation, protecting-group strategy, late-stage functionalization, purification, and structural characterization to develop a project-specific synthesis plan for the requested molecule or analog series.
Yes. BOC Sciences can design labeled and functionalized ether lipids with stable isotopes such as 2H, 13C, and 15N, fluorescent reporters, click-compatible groups including azides, alkynes, and DBCO, or affinity tags such as biotin. Functional groups can be introduced into the hydrophobic chain, headgroup, spacer, or another synthetically accessible position depending on the target architecture. The modification strategy is planned together with the ether lipid synthesis route to maintain compatibility with key bond-forming and purification steps. These customized lipids can support lipidomics, quantitative MS, metabolic tracing, membrane studies, bioorthogonal labeling, and lipid interaction research.
BOC Sciences took on a phytanyl-chain diether phospholipid that other suppliers had declined. They proposed an alternative protecting-group strategy, kept the sn-configuration intact, and delivered a clean product with full spectral data on the first attempt.
— Dr. Collins, Group Leader, Membrane Biophysics
The team walked us through the NMR assignments for our plasmalogen batch, including the vinyl ether region, and explained how MS/MS fragments distinguished the plasmenyl species from its plasmanyl analog. That level of analytical support made our reviewer responses much easier.
— Dr. Reyes, Manager, Lipidomics Core Facility
Each delivery arrived with a complete analytical package — HPLC purity traces, NMR spectra, and accurate-mass confirmation — presented in a format our quality colleagues could review without follow-up questions. The documentation is as reliable as the material itself.
— Mitchell, Senior Scientist, Drug Delivery Research
Progress updates arrived at every stage, from building block preparation to final purification, and technical questions about isotope placement were answered within a day. The transparency made a long-distance collaboration feel straightforward.
— Gonzalez, Project Manager, Lipid Therapeutics Program
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
